F
Über
Felice Verduyn - Van Weegen is identified as a responsible advisor for Amolyt Pharma, a company focused on creating treatment options for rare endocrine disorders. Amolyt Pharma was under the LSP 6 fund and exited in 2024.
Schwerpunkte
Healthcare
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...